0001104659-23-081298.txt : 20230815 0001104659-23-081298.hdr.sgml : 20230815 20230714171525 ACCESSION NUMBER: 0001104659-23-081298 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MedTech Acquisition Corp CENTRAL INDEX KEY: 0001826667 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 853009869 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 BUSINESS PHONE: 415 336 8917 MAIL ADDRESS: STREET 1: 6272 WEST 91ST AVENUE CITY: WESTMINSTER STATE: CO ZIP: 80031 FORMER COMPANY: FORMER CONFORMED NAME: MedTech Acquisition Corp DATE OF NAME CHANGE: 20200930 CORRESP 1 filename1.htm

 

MEDTECH ACQUISITION CORPORATION 

48 Maple Avenue 

Greenwich, Connecticut 06830

 

July 14, 2023

 

VIA EDGAR Correspondence

 

United States Securities and Exchange Commission 

Division of Corporation Finance 

Office of Industrial Applications and Services 

100 F. Street, N.E. 

Washington, D.C. 20549 

Attn: Ms. Jessica Ansart

 

Re:Acceleration of Effective Date
  MedTech Acquisition Corp
  Registration Statement on Form S-4 (File No. 333-269138)

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), MedTech Acquisition Corporation (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement (the “Registration Statement”) be accelerated so that the Registration Statement becomes effective under the Securities Act at 4:00 p.m., Eastern Time, on Monday, July 17, 2023, or as soon thereafter as practicable.

 

The Registrant respectfully requests that you notify Mr. Kevin Schuler of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-5441 or via email at kshuler@foley.com.

 

  Very truly yours,
   
  MedTech Acquisition Corporation

 

  By: /s/ Christopher C. Dewey
      Christopher C. Dewey
      Chief Executive Officer